NCT04043234

Brief Summary

This study will compare the use of RESCU \[Experimental\] Prosthesis with a \[Standard\] pattern recognition prosthesis in a clinical setting and in unsupervised daily activity. The protocol will follow a single case experimental design (SCED) to compensate for the limited size of the patient population. Each of the participants will use the Standard and Experimental and systems over a 35-day period. The Standard system will include at least two controllable DoFs (hand, wrist, multi-articulated hand, etc) and a commercially-available pattern recognition controller. The RESCU system will use the same components as the Standard system but will differ with respect to incorporating eight IBT Element Electrodes (as required for pattern recognition control) and the RESCU control software. The hypothesis is that pattern recognition will outperform the commercially-available control strategy for most participants on in-clinic, at-home usage, and subjective measures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 31, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 2, 2019

Completed
4.3 years until next milestone

Study Start

First participant enrolled

November 7, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 19, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 19, 2023

Completed
4 months until next milestone

Results Posted

Study results publicly available

April 24, 2024

Completed
Last Updated

April 24, 2024

Status Verified

April 1, 2024

Enrollment Period

1 month

First QC Date

July 31, 2019

Results QC Date

January 8, 2024

Last Update Submit

April 23, 2024

Conditions

Keywords

upper limbamputationprosthesismyoelectricpattern recognition

Outcome Measures

Primary Outcomes (1)

  • Mean Daily Prosthesis Use Duration

    Prosthesis usage time was monitored as a proxy for user satisfaction, under the assumption that when an individual is more satisfied with their prosthetic solution, they will use it more in their daily lives. For the experimental intervention, the mean daily prosthesis use duration is reported as the average number of hours the prosthesis was used daily over the evaluation period (i.e., four weeks). For the control intervention, the mean daily prosthesis use duration is reported as the average number of hours the prosthesis was used daily before the evaluation period (i.e., at baseline).

    Baseline, 4 weeks

Secondary Outcomes (7)

  • Activities Measure for Upper Limb Amputees (AM-ULA)

    Baseline, Post-Fitting, Post-Intervention

  • Orthotics and Prosthetics User's Survey Upper Extremity Functional Status (OPUS UEFS)

    Baseline, Post-Intervention

  • Trinity Amputation and Prosthesis Experience Survey for Upper Limb Amputation (TAPES-ULA)

    Baseline, Post-Intervention

  • PROMIS Satisfaction Short Form 8a

    Baseline, Post-Intervention

  • Pain Scale

    Baseline, Post-Fitting, Post-Intervention

  • +2 more secondary outcomes

Study Arms (1)

Single-Case Experimental Design

EXPERIMENTAL

Participants act as their own controls. They first use the Control device, which includes the pattern recognition controller, 8 electrodes, batteries, socket, frame, and prosthesis terminal device (hand/wrist/elbow). Participants are then transitioned to the Experimental device, which includes the RESCU controller, Apple iPad, 8 electrodes, batteries, socket, frame, and prosthesis terminal device (hand/wrist/elbow).

Device: RESCUDevice: Pattern Recognition

Interventions

RESCUDEVICE

Retrospectively Supervised Classification Updating (RESCU) is founded on two innovations that promise significant improvement in performance and outcome. The first is a highly robust machine intelligence algorithm, an Extreme Learning Machine with Adaptive Sparse Representation (EASRC), and the second is a novel adaptive learning algorithm and communication interface we call Nessa. We contend that these two technologies allow the prosthetic device to adapt to its user from the initial fitting through continuing, long-term use in the activities of daily living, shifting the paradigm of training from the current prospective data gathering methods to a more dynamic retrospective application.

Single-Case Experimental Design

Pattern recognition prostheses associate the patterns of activity of multiple EMG sites to the action of a prosthesis. Such strategies have historically required prospective calibration of the EMG activation patterns.

Single-Case Experimental Design

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Trans-radial limb difference.
  • Candidate for a 2+ degree-of-freedom (DoF) myoelectric pattern recognition prosthesis as determined by the study prosthetist
  • Active pattern recognition myoelectric prosthesis user
  • Fluent in English
  • Age of 18 years or greater

You may not qualify if:

  • Patients with a residual limb that is unhealed from the amputation surgery
  • Patients with easily damaged or sensitive skin who would not tolerate EMG electrodes
  • Unhealed wounds
  • Significant cognitive deficits as determined upon clinical evaluation
  • Significant neurological deficits as determined upon clinical evaluation
  • Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation
  • Uncontrolled pain or phantom pain impacting full participation in the study as determined upon clinical evaluation
  • Serious uncontrolled medical problems as judged by the project therapist

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical Center O&P

Silver Spring, Maryland, 20910, United States

Location

Results Point of Contact

Title
Chief Executive Officer
Organization
Infinite Biomedical Technologies, LLC

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Allocation
NA
Masking
NONE
Masking Details
The occupational therapist who graded the AM-ULA functional assessment was masked to participant IDs and intervention
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: Single-Case Experimental Design (SCED)
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Executive Officer

Study Record Dates

First Submitted

July 31, 2019

First Posted

August 2, 2019

Study Start

November 7, 2023

Primary Completion

December 19, 2023

Study Completion

December 19, 2023

Last Updated

April 24, 2024

Results First Posted

April 24, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations